In late 2026, the industry is pivoting toward "Off-the-Shelf Corneal Implants." This year, a radical new class of Synthetic Lamellar Grafts is being used to treat corneal blindness without the need for a human donor. Using data from these "Donor-Independent" surgeries, the Ocular Implants Market is reducing the global waitlist for transplants, which previously left millions in the dark. This...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek